Skip to main content
. 2019 Dec 31;9:20410. doi: 10.1038/s41598-019-56999-3

Table 6.

Cost-effectiveness of Ferric Carboxymaltose treatment (per patient and chemotherapy cycle).

Retrospective Control group Prospective group
Total cost per patient 80.76 € 78.76 €
Total cost per ChT cycle 11.35 € 10.79 €
Incremental cost per patient − 2.00 €
Incremental cost per ChT cycle ---- − 0.56 €

Costs were calculated considering the total number of patients and chemotherapy cycles described in Table 3.